If your primary care doctor recently told you that your liver enzymes are high or that an ultrasound showed a "fatty liver," you are not alone. Non-alcoholic fatty liver disease (NAFLD) — now also called metabolic dysfunction-associated steatotic liver disease (MASLD) — affects roughly 1 in 3 American adults, and rates in Northeast Florida track closely with the national average. The good news: for most patients, fatty liver weight loss in Jacksonville is the single most powerful, evidence-based way to shrink liver fat, normalize enzymes, and often fully reverse the condition before it becomes scarring or cirrhosis.

This guide walks through what NAFLD actually is, the weight-loss targets that move the needle, the labs we track, and how a doctor-led clinic coordinates with hepatology when your case calls for it.

NAFLD is the buildup of excess fat inside liver cells in people who drink little to no alcohol. It exists on a spectrum:

• Simple steatosis — fat in the liver without inflammation. Often silent, often reversible.
• NASH (non-alcoholic steatohepatitis) — fat plus inflammation and liver-cell injury. Higher risk of progression.
• Fibrosis — early scarring as the liver tries to heal itself.
• Cirrhosis — advanced, permanent scarring that can impair liver function.

It is worth noting, for medical literacy, that alcoholic fatty liver disease is a separate diagnosis driven by alcohol intake; it can look similar on imaging but is managed differently. NAFLD, by contrast, is metabolic — closely tied to insulin resistance, type 2 diabetes, high triglycerides, central obesity, and obstructive sleep apnea.

There is currently no single medication that cures NAFLD across the board. What the data consistently show is that sustained weight loss reverses liver fat in a dose-dependent way:

• 3–5% body weight loss — meaningful reduction in liver fat (steatosis).
• 7–10% body weight loss — resolution of NASH inflammation in most patients.
• 10%+ body weight loss — regression of early fibrosis in a meaningful subset of patients.

For a 220-lb adult in Jacksonville, that means a target of roughly 15–22 lbs lost and kept off. Crash diets do not get you there; structured, doctor-supervised care does.

At MedexClinic in Jacksonville, FL, our weight-loss program is led by Dr. Asim Nouman, MD, an experienced family physician with 18+ years of clinical practice in weight loss and obesity medicine. For NAFLD patients, the workup typically includes a metabolic history, body composition assessment, lab panel, and a personalized plan that may combine nutrition, activity, and — when appropriate — GLP-1 medications such as semaglutide or tirzepatide, which have shown meaningful liver-fat reduction in clinical trials.

We see patients from across Northeast Florida, including Mandarin, San Marco, Riverside, Baymeadows, Westside, Orange Park, and St. Augustine, at our two Jacksonville offices.

You cannot reverse what you do not measure. The labs and studies we typically follow for a NAFLD patient include:

• ALT and AST — liver enzymes; ALT is often the most sensitive marker of liver-cell injury.
• GGT and alkaline phosphatase — additional liver markers, helpful when the pattern is unclear.
• Fasting glucose, insulin, and HbA1c — because insulin resistance drives NAFLD.
• Lipid panel — triglycerides and HDL are often the first to shift.
• FIB-4 index — a calculated score (age, AST, ALT, platelets) that estimates fibrosis risk.
• Vibration-controlled transient elastography (FibroScan) — when available, non-invasively measures liver stiffness and fat.
• Hepatitis B and C panel, iron studies, TSH — to rule out other causes of elevated enzymes.

We typically recheck enzymes and metabolic markers every 8–12 weeks once a treatment plan is in motion, so you can see your progress in real numbers, not just on the scale.

Most early NAFLD is managed effectively in a primary care and weight-medicine setting. We refer to a hepatologist (liver specialist) in Jacksonville when the picture suggests more than simple fatty liver — for example:

• FIB-4 score in the intermediate or high-risk range
• FibroScan suggesting significant fibrosis
• Persistently elevated ALT/AST despite weight loss and metabolic improvement
• Suspected NASH with overlapping autoimmune, viral, or genetic liver disease
• Signs of advanced disease (low platelets, low albumin, abnormal coagulation)

The clinic's role does not end at the referral — we continue managing weight, blood sugar, blood pressure, and lipids in parallel, because those metabolic drivers are what created the liver problem in the first place.

There is no single "fatty liver diet," but the patterns that consistently lower liver fat share these traits:

• Lower refined carbohydrates and added sugars — especially sugar-sweetened beverages and high-fructose foods, which are directly converted to liver fat.
• Lean proteins — chicken, turkey, fish, eggs, beef, lamb, lentils, chickpeas, tofu.
• Mediterranean-style fats — olive oil, avocado, nuts, seeds, fatty fish like salmon and sardines (omega-3s help reduce liver triglycerides).
• High-fiber vegetables and whole fruit — at least half the plate at most meals.
• Cooking with broth, stock, lemon juice, or balsamic vinegar instead of sugary sauces.
• Coffee — observational data consistently link 2–3 cups daily with lower liver fibrosis risk.

From a medical-literacy standpoint, alcohol intake is an independent driver of liver injury and is generally discouraged in any patient with fatty liver disease, regardless of subtype.

Many patients see ALT and AST trend downward within 8–12 weeks of consistent weight loss and metabolic improvement. Liver fat on imaging often improves at the 3–6 month mark. Fibrosis, if present, takes longer to remodel — typically 12+ months of sustained change. The takeaway: this is a marathon you can absolutely win, but it requires structured follow-up, not a one-and-done visit.

For carefully selected patients, GLP-1 medications such as semaglutide and tirzepatide are not only safe in NAFLD — they have shown reductions in liver fat and improvements in liver enzymes in multiple trials. Candidacy depends on your full medical history, current medications, and lab profile, which is why this is a doctor-led decision, not a self-ordered subscription.

If you have been told you have fatty liver, mildly elevated liver enzymes, prediabetes, or metabolic syndrome, the next step is a focused visit with a physician who treats this every day. MedexClinic has two Jacksonville locations — Baymeadows (9551 Baymeadows Rd, Suite 6) and Westside (1395 Cassat Ave, Suite 3) — and serves patients across Mandarin, San Marco, Riverside, Orange Park, and St. Augustine. Call (904) 444-2903 or book online below.

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Diagnosis and treatment of fatty liver disease, including any medication decisions, should be made with a qualified physician who knows your full medical history.